Researchers from Yale University found that exposure to rhinovirus, the most common virus that causes the cold, can jump-start the immune system and protect people against the Wuhan coronavirus (COVID-19).
Article by Arsenio Toledo from Natural News.
The presence of the virus that causes the common cold can begin the activity of interferon-stimulated genes. These are some of the early-response molecules in the immune system. If a person with the cold inhales SARS-CoV-2, the virus that causes COVID-19, there is a chance that it cannot replicate if it lands in the same airway tissues that are infected with the cold. (Related: If you’ve ever had a cold, your immune system may already know how to fight COVID-19.)
The new study, published on Tuesday, June 15 in the Journal of Experimental Medicine, examined rhinoviruses. These researchers had previously found that the immune system’s response to the common cold can protect people against the flu. They wanted to see if this kind of response could be replicated and offer similar protection against COVID-19.
They used human airway tissue grown in a lab for this experiment. The researchers infected the artificial tissue with the rhinovirus and then with the coronavirus. After the tissue was exposed to the rhinovirus, its immune system was automatically activated. The tissue with the rhinovirus was then infected with SARS-CoV-2. The virus was completely stopped from replicating.
The team compared the results by infecting a clean piece of lab-grown tissue with the coronavirus. They found that the viral load in this sample of tissue doubled every six hours.
They also found out that the body can slow down the spread of SARS-CoV-2 even without an initial rhinovirus infection if the infectious dose was very low. This suggests that the viral load at the time of exposure makes a difference in whether the body can fight off the coronavirus.
Triggering immune system responses early can prevent coronavirus infection
Ellen Foxman, senior author of the study, said there is a chance people can prevent a COVID-19 infection or treat it early by triggering these immune system responses. Foxman is also an assistant professor of laboratory medicine and immunobiology at Yale’s School of Medicine.
“But it all depends upon the timing,” said Foxman. “There appears to be a viral sweet spot at the beginning of COVID-19, during which the virus replicates exponentially before it triggers a strong defense response.”
One way Foxman said people can trigger their immune systems is by treating early-stage COVID-19 patients with interferon, an immune system protein.
Foxman explained that interferon treatment holds promise, but it is very tricky. Interferon might only be effective in the days immediately after a person gets infected with COVID-19. During this time, the infection is still spreading and most people still do not have any symptoms.
She adds that, at least in theory, people at high risk of getting COVID-19 or who have been in close contact with people diagnosed with the virus could use interferon as a prophylactic.
In fact, trials studying interferon’s effectiveness in dealing with COVID-19 are already underway. Preliminary data from these studies shows there is a possible benefit to using interferon early in infection, but not when it is given during its later stages.
Foxman and the other researchers believe their study can help explain why at times of the year when colds are more common, rates of infections with other viruses like influenza tend to decrease. This interference between different respiratory viruses could mitigate the spread of other, deadlier viruses by creating an “upper limit” on the degree to which they could co-circulate.
“There are hidden interactions between viruses that we don’t quite understand, and these findings are a piece of the puzzle we are just now looking at,” said Foxman.
Joe Biden is doing everything in his power to annihilate our economy on behalf of China and the globalist elites. Contact Ira and he’ll show you how easy it is move cash, investments, or retirement into PHYSICAL precious metals without the gimmicks or runaround.
New Conservative Network Seeks Crowdfunding Help
They say we have to go big or go home. We’re trying to go big and bring the patriotic truth the the nation, but we need help.
Readers may or may not realize that over the past year, we’ve been bringing more conservative news and opinion outlets under our wing. Don’t take our expansion as a sign of riches; all of the “acquisitions” have been through sweat and promises of greater things to come for all involved. As a result, we’ve been able to bring together several independent media sites under a unified vision of preventing America from succumbing to the progressive, “woke,” Neo-Marxist ideologies that are spreading like wildfire across America.
The slow and steady reopening of America is revealing there was a lot more economic hardship brought about from the Covd-19 lockdowns than most realize. While we continue to hope advertising dollars on the sites go up, it’s simply not enough to do things the right way. We are currently experiencing a gap between revenue and expenses that cannot be overcome by click-ads and MyPillow promos alone (promo code “NOQ” by the way).
To overcome our revenue gap and keep these sites running, our needs fluctuate between $3000-$7000 per month. In other words, we’re in the red and hemorrhaging.
The best way you can help us grow and continue to bring the truth to the people is by donating. We appreciate everything, whether a dollar or $10,000. Anything brings us closer to a point of stability when we can hire writers, editors, and support staff to make the America First message louder. Our Giving Fuel page makes it easy to donate one-time or monthly. Alternatively, you can donate through PayPal as well.
As the world spirals towards radical progressivism, the need for truthful journalism has never been greater. But in these times, we need as many conservative media voices as possible. Please help keep NOQ Report and the other sites in the network going.
Thank you and God Bless,